Operating Segment Information (Tables)

6 Months Ended

Mar. 31, 2015

Segment Reporting [Abstract]

Segment Revenue, Operating Income and Depreciation and Amortization

The tables below present segment revenue, operating income and depreciation and amortization, as follows:

	Three Months Ended March 31,						Six Months Ended March 31,
(Dollars in thousands)	2015			2014			2015			2014
Revenue:
Medical Device	$	10,562		$	10,482		$	21,198		$	21,031
In Vitro Diagnostics		3,853			3,122			7,422			6,456
Total revenue	$	14,415		$	13,604		$	28,620		$	27,487
Operating income:
Medical Device	$	4,696		$	5,282		$	10,212		$	10,610
In Vitro Diagnostics		931			633			2,028			1,303
Total segment operating income		5,627			5,915			12,240			11,913
Corporate		(1,695	)		(2,435	)		(3,274	)		(4,104	)
Total operating income	$	3,932		$	3,480		$	8,966		$	7,809
Depreciation and amortization:
Medical Device	$	295		$	287		$	565		$	581
In Vitro Diagnostics		216			213			430			427
Corporate		195			184			394			372
Total depreciation and amortization	$	706		$	684		$	1,389		$	1,380